Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 9 results.
User Information
Export Records
  1. 1.   Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies
  2. Kummar, S.; Kinders, R.; Gutierrez, M. E.; Rubinstein, L.; Parchment, R. E.; Phillips, L. R.; Ji, J. P.; Monks, A.; Low, J. A.; Chen, A.; Murgo, A. J.; Collins, J.; Steinberg, S. M.; Eliopoulos, H.; Giranda, V. L.; Gordon, G.; Helman, L.; Wiltrout, R.
  3. Journal of Clinical Oncology. 2009 27(16): 2705-2711.
  1. 2.   Potent inhibition of human apurinic/apyrimidinic endonuclease 1 by arylstibonic acids
  2. Seiple, L. A.; Cardellina, J. H.; Akee, R.; Stivers, J. T.
  3. Molecular Pharmacology. 2008 73(3): 669-677.
  1. 3.   Switches in bacteriophage lambda development
  2. Oppenheim, A. B.; Kobiler, O.; Stavans, J.; Court, D. L.; Adhya, S.
  3. Annual Review of Genetics. 2005 39: 409-429.
  1. 4.   Eradication of HIV in infected patients: Some potential approaches
  2. Yang, Q. E.
  3. Medical Science Monitor. 2004, JUL; 10(7): RA155-RA165.
  1. 5.   Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: Mechanism and therapeutic implications
  2. Rapisarda, A.; Uranchimeg, B.; Sordet, O.; Pommier, Y.; Shoemaker, R. H.; Melillo, G.
  3. Cancer Research. 2004 64(4): 1475-1482.
  1. 6.   Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53
  2. Hildesheim, J.; Bulavin, D. V.; Anver, M. R.; Alvord, W. G.; Hollander, M. C.; Vardanian, L.; Fornace, A. J.
  3. Cancer Research. 2002 62(24): 7305-7315.
  1. 7.   An informatics approach identifying markers of chemosensitivity in human cancer cell lines
  2. Amundson, S. A.; Myers, T. G.; Scudiero, D.; Kitada, S.; Reed, J. C.; Fornace, A. J.
  3. Cancer Research. 2000 60(21): 6101-6110.
  1. 8.   Characterization of the P53 Tumor Suppressor Pathway in Cell Lines of the National Cancer Institute Anticancer Drug Screen and Correlations With the Growth-Inhibitory Potency of 123 Anticancer Agents
  2. Oconnor, P. M.; Jackman, J.; Bae, I.; Myers, T. G.; Fan, S. J.; Mutoh, M.; Scudiero, D. A.; Monks, A.; Sausville, E. A.; Weinstein, J. N.; Friend, S.; Fornace, A. J.; Kohn, K. W.
  3. Cancer Research. 1997 57(19): 4285-4300.
  1. 9.   Proteolytic Cleavage of Human P53 By Calpain - a Potential Regulator of Protein Stability
  2. Kubbutat, M. H. G.; Vousden, K. H.
  3. Molecular and Cellular Biology. 1997 17(1): 460-468.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel